Cost-utility of nintedanib vs. Pirferidone in the treatment of idiopathic pulmonary fibrosis in spain
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1207
https://www.valueinhealthjournal.com/article/S1098-3015(16)32573-6/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1134
First Page :
A555
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32573-6&doi=10.1016/j.jval.2016.09.1207